Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Expert Opinion on Therapeutic Targets
|
September 12, 2002
Airway smooth muscle: new targets for asthma pharmacotherapy
Aili L Lazaar
Current Opinion in Molecular Therapeutics
|
April 3, 2003
Technology evaluation: omalizumab, Genentech/Novartis/Tanox
Aili L Lazaar
Clinics in Chest Medicine
|
March 18, 2006
Airway smooth muscle as a regulator of immune responses and bronchomotor tone
Aili L Lazaar, Reynold A Panettieri
The European Respiratory Journal
|
November 2, 2012
Impaired muscle mitochondrial density and/or function: a COPD-specific mitochondropathy or simply deconditioning?
Aili L Lazaar, Paul L Greenhaff
The American Journal of Medicine
|
December 6, 2003
Is airway remodeling clinically relevant in asthma?
Aili L Lazaar, Reynold A Panettieri
The Journal of Allergy and Clinical Immunology
|
September 15, 2005
Airway smooth muscle: a modulator of airway remodeling in asthma
Aili L Lazaar, Reynold A Panettieri
Pulmonary Pharmacology & Therapeutics
|
May 25, 2013
Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD
Henrik Watz, Sunil J Mistry, Aili L Lazaar, et al.
Respiratory Research
|
March 3, 2010
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Dave Singh, Frank Petavy, Alex J Macdonald, et al.
Chest
|
April 2, 2011
Elevated airway purines in COPD
Charles R Esther, Aili L Lazaar, Elena Bordonali, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 11, 2017
Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase
Svetlana L Belyanskaya, Yun Ding, James F Callahan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Expert Opinion on Therapeutic Targets
|
September 12, 2002
Airway smooth muscle: new targets for asthma pharmacotherapy
Aili L Lazaar
Current Opinion in Molecular Therapeutics
|
April 3, 2003
Technology evaluation: omalizumab, Genentech/Novartis/Tanox
Aili L Lazaar
Clinics in Chest Medicine
|
March 18, 2006
Airway smooth muscle as a regulator of immune responses and bronchomotor tone
Aili L Lazaar, Reynold A Panettieri
The European Respiratory Journal
|
November 2, 2012
Impaired muscle mitochondrial density and/or function: a COPD-specific mitochondropathy or simply deconditioning?
Aili L Lazaar, Paul L Greenhaff
The American Journal of Medicine
|
December 6, 2003
Is airway remodeling clinically relevant in asthma?
Aili L Lazaar, Reynold A Panettieri
The Journal of Allergy and Clinical Immunology
|
September 15, 2005
Airway smooth muscle: a modulator of airway remodeling in asthma
Aili L Lazaar, Reynold A Panettieri
Pulmonary Pharmacology & Therapeutics
|
May 25, 2013
Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD
Henrik Watz, Sunil J Mistry, Aili L Lazaar, et al.
Respiratory Research
|
March 3, 2010
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Dave Singh, Frank Petavy, Alex J Macdonald, et al.
Chest
|
April 2, 2011
Elevated airway purines in COPD
Charles R Esther, Aili L Lazaar, Elena Bordonali, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 11, 2017
Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase
Svetlana L Belyanskaya, Yun Ding, James F Callahan, et al.
Page
of 4